✦ LIBER ✦

Clinical impact of molecular diagnostics in low-grade lymphoma

✍ Scribed by Mariem Bahloul; Vahid Asnafi; Elizabeth Macintyre

Book ID: 119195223
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 150 KB
Volume: 18
Category: Article
ISSN: 1521-6926
DOI: 10.1016/j.beha.2004.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DIAGNOSTIC VALUE OF IMMUNOPHENOTYPING IN

DIAGNOSTIC VALUE OF IMMUNOPHENOTYPING IN LOW-GRADE B-CELL LYMPHOMA

✍ W. Eisterer; W. Hilbe; C. Ludescher; F. Fend; J. Thaler; M. Schwonzen; T. Steinm 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

Progress in the molecular diagnostics of

Progress in the molecular diagnostics of lymphoma

✍ P.W.M. Johnson 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Results of involved field radiotherapy i

Results of involved field radiotherapy in clinical stage I–II LOW GRADE LYMPHOMA

✍ Mary K. Gospodarowicz; S.B. Sutcliffe; W.A. Wells; R. Tsang 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Low-grade B-cell MALT lymphoma of the st

Low-grade B-cell MALT lymphoma of the stomach: a clinical challenge

✍ A. Tursi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 60 KB

Molecular Phenotype Distinguishes Two Su

Molecular Phenotype Distinguishes Two Subsets of Gastric Low-Grade Mucosa-Associated Lymphoid Tissue Lymphomas

✍ Nardini, Elena; Rizzi, Simona; Ménard, Sylvie; Balsari, Andrea 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 728 KB

High activity of mitoxantrone in previou

High activity of mitoxantrone in previously untreated low-grade lymphomas

✍ Steen Werner Hansen; Nis I. Nissen; Mogens Mørk Hansen; Klaus Hou-Jensen; Jens P 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 269 KB

A consecutive series of 21 previously untreated patients with low-grade non-Hodgkin lymphomas were treated with mitoxantrone 5 mg/m2 daily for 3 days every 3 weeks. The cumulative dose did not exceed 165 mg/m2 in any patient. In this group, 7 patients had small lymphocytic lymphomas, 10 patients had